News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Photo from Paolo Tarantino/Twitter
Oct 2, 2023, 22:37

Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.

Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow at the Dana-Farber Cancer Institute, shared the following insights on Twitter:

“Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer. Yet, they have only partly fulfilled the promise of the “magic bullet”, given that they’re commonly burdened with chemotherapy-related side effects (e.g. nausea, neutropenia, alopecia) as well as some less understood toxicities.

Thanks to Medscape for this interview on ADCs toxicities and for highlighting our recent article published on Nature Reviews (for details click here).

Looking forward to discussing more about this important topic with Patricia LoRusso, Elisabeth De Vries, Raffaele Colombo, Anthony Tolcher at the upcoming AACR-NCI-EORTC “Triple Meeting” (Plenary Session II). (For details click here).

For details click here.
Source: Paolo Tarantino/LinkedIn

Anthony Tolcher Antibody drug conjugates cancer Elisabeth De Vries European Institute of Oncology Nature Reviews OncoDaily Oncology Paolo Tarantino Patricia LoRusso Raffaele Colombo
Special Coverage
Insight
May 10, 2025, 23:57
Michael Jefford: Understanding experiences of optimal survivorship care
Blog
May 10, 2025, 22:44
New postdoc opportunity at IARC studying the causes of cancer in diverse populations
Blog
May 10, 2025, 21:51
Join Dana-Farber’s Breast Oncology Center for a day of finding balance through wellness, education and community
Blog
May 10, 2025, 20:06
Zainab Shinkafi-Bagudu Honors UICC President Ulrika Årehed Kågström on Her Birthday
Blog
May 10, 2025, 19:24
Dato' Dr Saunthari Somasundaram: I had the privilege of speaking with Anita Abu Bakar on a topic close to both our hearts
Blog
May 10, 2025, 19:04
Elizabeth Ugwoma Awo-Ejeh: Mental stress is something we hardly talk about, yet it's something almost everyone carries
Insight
May 10, 2025, 18:11
Digestive Cancers Europe highlights Sara Ben Hmido’s study on patient perspectives of AI in surgical decision-making
Blog
May 10, 2025, 18:03
April Dorenbosch discussed migrant struggles with cancer care in Europe in Youth Cancer Europe interview
Insight
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
Blog
May 10, 2025, 17:48
Manette Le Grange Highlights ACT for Children Initiative in Pediatric Cancer Care
Blog
May 10, 2025, 17:44
Ashish Shah Explores Viral Mimicry Approach to Glioblastoma at Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research